Authors: Frasci, G Comella, P D'Aiuto, G Thomas, R Capasso, I Elmo, M Botti, G Cortino, GR Lapenta, L De Rosa, V Vallone, P Petrillo, A Comella, G

Citation: G. Frasci et al., Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study, ANN ONCOL, 11(3), 2000, pp. 367-371

Authors: Frasci, G D'Aiuto, G Comella, P Thomas, R Capasso, I Di Bonito, M Rivellini, F Carteni, G De Lucia, L Maiorino, L D'Aniello, R Frezza, P Lapenta, L Comella, G

Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study, BREAST CANC, 62(2), 2000, pp. 87-97

Authors: Frasci, G Panza, N Comella, P Carteni, G Guida, T Nicolella, GP Natale, M Lombardi, R Apicella, A Pacilio, C Gravina, A Lapenta, L Comella, G

Citation: G. Frasci et al., Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study, ANN ONCOL, 10(3), 1999, pp. 355-358

Authors: Frasci, G D'Aiuto, G Comella, P Apicella, A Thomas, R Capasso, I Di Bonito, M Carteni, G Biglietto, M Lucia, LD Maiorino, L Piccolo, S Bianchi, U D'Aniello, R Lapenta, L Comella, G

Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group, BREAST CANC, 56(3), 1999, pp. 239-252